2invest AG

€6.32As of Sun 8 Nov 2026, 12:00 UTC
FRA:2INVHealthcare
Country Germany
PE (Fwd) •••
TSR 10Y CAGR (4.86%)
Div yield —
ROE (10.88%)
Biological Products, Except Diagnostic Substances
Beta (5Y) (0.03)
PE TTM —
TSR TTM (49.84%)
Mkt cap €34.74M
ROIC 0.58%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€6.34
0.30%
(83.46%)
Hold 0|5|3|3|1
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.07
0.08
0.08
0.08
19.72%
29.52%
26.51%
28.83%
Revenue€M
2.450
2.422
2.373
2.392
9.95%
6.98%
(1.08%)
2.34%
Peers (US$39.01M)
Cap (US$)
PE
84.89M
—
38.76M
50.39x
Capital
TTM
5Y
10Y
Leveragex
0.480
0.012
0.013
EBIT/Intx
3.110
0.311
0.286
Own earn%
69.48
(26.04)
(34.73)
Sh yield%
31.19
36.44
37.20
Owners
Insiders/Inst%
9.98
78.05
Short interest%
1.95
SBC / revenue%
3.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
3–9
$1 testx
0.8
Incr. ROIC%
1